Please submit the form to connect with a member of our clinical development or business development teams. If you prefer to send us an email, you can reach us at BD@prosciento.com.
Our Specialized Expertise in Clinical Research for Metabolic Continuum Diseases
ProSciento’s core strengths lie in our unparalleled expertise in metabolic continuum diseases and our ability to conduct early stage (Phase 1 through 2b) clinical trials with exceptional scientific rigor and operational precision. We are especially renowned for our capabilities in designing protocols, optimizing clinical trial design, and developing effective enrollment strategies. These full-scope services (from clinical development and regulatory submissions through trial conduct, data analysis, and publication) help sponsors achieve early decision milestones, gather high-quality data to support ongoing clinical development, and, when relevant, secure licensing opportunities.
Full-Scope Services, Customized for Our Clients
Rather than require the study sponsor to fit into a set mold of CRO services, ProSciento prioritizes a nimble, responsive partnership that fits the specialized needs of each specific study and sponsor.
Sponsors have access to a full scope of CRO services and our team works closely with each sponsor so that a set of services are customized for each study. Sponsors further benefit from a highly responsive team supporting their study, including direct access to senior leadership and scientific advisors.
We look forward to discussing how we can support your advancements in research and your therapeutic or device development for metabolic diseases.